IL131171A0 - Factor x deletion mutants and analogues thereof and preparations containing the same - Google Patents

Factor x deletion mutants and analogues thereof and preparations containing the same

Info

Publication number
IL131171A0
IL131171A0 IL13117198A IL13117198A IL131171A0 IL 131171 A0 IL131171 A0 IL 131171A0 IL 13117198 A IL13117198 A IL 13117198A IL 13117198 A IL13117198 A IL 13117198A IL 131171 A0 IL131171 A0 IL 131171A0
Authority
IL
Israel
Prior art keywords
analogues
factor
same
preparations containing
deletion mutants
Prior art date
Application number
IL13117198A
Other languages
English (en)
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of IL131171A0 publication Critical patent/IL131171A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IL13117198A 1997-02-27 1998-02-27 Factor x deletion mutants and analogues thereof and preparations containing the same IL131171A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0033697A AT405517B (de) 1997-02-27 1997-02-27 Faktor x-deletionsmutanten und analoge davon
PCT/AT1998/000046 WO1998038318A1 (de) 1997-02-27 1998-02-27 Faktor x-deletionsmutanten und analoge davon

Publications (1)

Publication Number Publication Date
IL131171A0 true IL131171A0 (en) 2001-01-28

Family

ID=3487892

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13117198A IL131171A0 (en) 1997-02-27 1998-02-27 Factor x deletion mutants and analogues thereof and preparations containing the same
IL131171A IL131171A (en) 1997-02-27 1999-07-29 Factor x deletion mutants and analogues thereof and preparations containing the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL131171A IL131171A (en) 1997-02-27 1999-07-29 Factor x deletion mutants and analogues thereof and preparations containing the same

Country Status (17)

Country Link
US (2) US6562598B1 (cs)
EP (1) EP1012303B1 (cs)
JP (1) JP4108761B2 (cs)
AR (1) AR010119A1 (cs)
AT (2) AT405517B (cs)
AU (1) AU732953B2 (cs)
BR (1) BR9807618A (cs)
CA (1) CA2282728A1 (cs)
CZ (1) CZ298296B6 (cs)
DE (1) DE59813745D1 (cs)
ES (1) ES2273405T3 (cs)
HU (1) HU225247B1 (cs)
IL (2) IL131171A0 (cs)
NO (1) NO328022B1 (cs)
PL (1) PL191778B1 (cs)
SK (1) SK282369B6 (cs)
WO (1) WO1998038318A1 (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT405516B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-analoge mit modifizierter proteasespaltstelle
AT405517B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-deletionsmutanten und analoge davon
GB9826747D0 (en) * 1998-12-05 1999-01-27 Zeneca Ltd Chemical compounds
AT410216B (de) 1999-08-10 2003-03-25 Baxter Ag Faktor x-analogon mit verbesserter aktivierbarkeit
WO2001070763A1 (en) * 2000-03-22 2001-09-27 The Children's Hospital Of Philadelphia Modified blood clotting factors and methods of use
WO2004101598A2 (en) * 2003-05-09 2004-11-25 Research Development Foundation Insertion of furin protease cleavage sites in membrane proteins and uses thereof
EP1728798A1 (en) * 2005-06-01 2006-12-06 ZLB Behring GmbH Coagulation factor X polypeptides with modified activation properties
MX2008006313A (es) 2005-11-15 2008-11-06 Philadelphia Children Hospital Metodos y composiciones para modular la hemostasia.
GB2433592A (en) 2005-12-23 2007-06-27 Pentapharm Ag Assay for thrombin inhibitors
EP1820508A1 (en) * 2006-02-21 2007-08-22 CSL Behring GmbH Coagulation factor X polypeptides with modified activation properties
US20080050776A1 (en) * 2006-05-26 2008-02-28 Kenneth Neet Stable mutated pro nerve growth factors
EP3824902A1 (en) * 2007-09-28 2021-05-26 Portola Pharmaceuticals, Inc. Antidotes for factor xa inhibitors and methods of using the same
CN102316893B (zh) 2008-11-14 2015-02-18 博尔托拉制药公司 因子Xa抑制剂的解毒剂及其与血液凝固剂组合使用的方法
EP2414517B1 (en) 2009-03-30 2016-09-21 Portola Pharmaceuticals, Inc. Antidotes for factor xa inhibitors and methods of using the same
JP6163304B2 (ja) 2009-07-15 2017-07-12 ポートラ ファーマシューティカルズ， インコーポレイテッド 第Ｘａ因子インヒビターの解毒剤の単位用量処方物およびその使用方法
CA2850603C (en) 2011-09-30 2021-11-16 The Children's Hospital Of Philadelphia Compositions and methods for modulating hemostasis
CN104254603A (zh) * 2012-02-14 2014-12-31 博尔托拉制药公司 用于制备xa因子抑制剂的重组解毒剂的方法
MX365612B (es) 2012-07-25 2019-06-07 Catalyst Biosciences Inc Polipeptidos de factor x modificados y usos de los mismos.
AU2014210830A1 (en) * 2013-01-31 2015-07-16 Pfizer Inc. Compositions and methods for counteracting Factor Xa inhibition
WO2015044836A1 (en) 2013-09-24 2015-04-02 Pfizer Inc. Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins
US10676731B2 (en) 2014-08-19 2020-06-09 The Children's Hospital Of Philadelphia Compositions and methods for modulating factor IX function
CA3082043A1 (en) 2017-11-07 2019-05-16 Rani Therapeutics, Llc Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT366916B (de) * 1980-04-02 1982-05-25 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes auf basis von menschlichen oder tierischenproteinen
US4501731A (en) 1983-06-27 1985-02-26 Tishkoff Garson H Treatment of disparate bleeding disorders with factor X zymogen
AT382783B (de) * 1985-06-20 1987-04-10 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes
US5028424A (en) 1987-10-16 1991-07-02 University Of Georgia Research Foundation Antibodies to receptor and antigen for natural killer and non-specific cytotoxic cells
US5597799A (en) * 1990-09-04 1997-01-28 Cor Therapeutics, Inc. Recombinant agents affecting thrombosis
IE914102A1 (en) 1990-11-26 1992-06-03 Genetics Inst Expression of pace in host cells and methods of use thereof
US5621039A (en) 1993-06-08 1997-04-15 Hallahan; Terrence W. Factor IX- polymeric conjugates
DE4325872C1 (de) 1993-08-02 1994-08-04 Immuno Ag Virusinaktivierte Faktor Xa-Präparation
AT401270B (de) * 1994-09-26 1996-07-25 Immuno Ag Verfahren zur quantifizierung von genomischer dna
AT404838B (de) 1995-11-24 1999-03-25 Immuno Ag Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
AT405517B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-deletionsmutanten und analoge davon
AT405516B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-analoge mit modifizierter proteasespaltstelle
US6582598B2 (en) * 2000-12-14 2003-06-24 Hubert Patrovsky Wave filter for rotary filter

Also Published As

Publication number Publication date
ES2273405T3 (es) 2007-05-01
JP4108761B2 (ja) 2008-06-25
BR9807618A (pt) 2000-02-15
US6905846B2 (en) 2005-06-14
AR010119A1 (es) 2000-05-17
PL191778B1 (pl) 2006-07-31
US20030138914A1 (en) 2003-07-24
IL131171A (en) 2007-05-15
ATA33697A (de) 1999-01-15
DE59813745D1 (de) 2006-11-09
NO328022B1 (no) 2009-11-09
HUP0000826A1 (en) 2000-07-28
WO1998038318A1 (de) 1998-09-03
HU225247B1 (en) 2006-08-28
AU732953B2 (en) 2001-05-03
AU6080898A (en) 1998-09-18
EP1012303B1 (de) 2006-09-27
CZ298296B6 (cs) 2007-08-22
HUP0000826A3 (en) 2002-01-28
EP1012303A1 (de) 2000-06-28
SK282369B6 (sk) 2002-01-07
NO994136D0 (no) 1999-08-26
AT405517B (de) 1999-09-27
CA2282728A1 (en) 1998-09-03
ATE340862T1 (de) 2006-10-15
JP2001513632A (ja) 2001-09-04
PL335379A1 (en) 2000-04-25
SK117099A3 (en) 2000-05-16
CZ303199A3 (cs) 2000-01-12
US6562598B1 (en) 2003-05-13
NO994136L (no) 1999-10-27

Similar Documents

Publication Publication Date Title
IL131171A0 (en) Factor x deletion mutants and analogues thereof and preparations containing the same
AU6360394A (en) Vasonatrin peptide and analogs thereof
ZA945720B (en) Electrode and preparation thereof
IL134068A (en) Mammalian cytokine: interleukin - b 30 and isolated polunucleotides encoding the same
EP0745670A4 (en) STABILIZED TRANSGLUTAMINASE AND ENZYMATIC PREPARATION CONTAINING THIS TRANSGLUTAMINASE
IL135646A0 (en) α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HUP9904031A3 (en) Insulin preparations containing nacl
ZA9684B (en) Composition and use
EP0445801A3 (en) Peptide and its use
GB2281830B (en) I/q-modulator and i/q-demodulator
ZA959517B (en) Leutherobin and analogs thereof
IL140742A0 (en) Raloxifene and pharmaceutical composition comprising the same
IL130348A0 (en) Imidazopyridazines and medicaments containing the same
GB2282601B (en) Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
PL310462A1 (en) Acetal containing mixture and application thereof
AU8603591A (en) Peptide and its use
GB9216776D0 (en) Composition and use
GB2309224B (en) Tamoxifen and analogues thereof
GB9306456D0 (en) Composition and use
GB2284418B (en) Z-Benzylidene-Tetrahydroquinolines and analogues thereof
GB9721036D0 (en) Spasminogenic preparations:methods and materials relating thereto
GB9408859D0 (en) Composition and use
GB9324725D0 (en) Ficyclic compounds and preparation thereof
GB9722392D0 (en) Composition and use
GB9417398D0 (en) New compounds and preparations thereof

Legal Events

Date Code Title Description
FF Patent granted
KB20 Patent renewed for 20 years